BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Barbara J. Gitlitz, MD
Jonsson Comprehensive Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- University of Colorado Cancer Center
Denver, Colorado, United States
- Oncology-Hematology Group of South Florida
Miami, Florida, United States
- Emory University Hospital - Atlanta
Atlanta, Georgia, United States
- Veterans Affairs Medical Center - Atlanta (decatur)
Decatur, Georgia, United States
- Dwight David Eisenhower Army Medical Center
Fort Gordon, Georgia, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Tulane University School of Medicine
New Orleans, Louisiana, United States
- Louisiana State University Health Sciences Center - Shreveport
Shreveport, Louisiana, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Ellis Fischel Cancer Center - Columbia
Columbia, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Norris Cotton Cancer Center
Lebanon, New Hampshire, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- University of Rochester Medical Center
Rochester, New York, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Oregon Cancer Institute
Portland, Oregon, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Cancer Centers of the Carolinas
Greenville, South Carolina, United States
- Simmons Cancer Center - Dallas
Dallas, Texas, United States
- Baylor College of Medicine
Houston, Texas, United States
- Cancer Therapy and Research Center
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- —
- Last update posted
- 10 Jul 2013
- Registered enrollment
- 0
- Registry id
- NCT00040989
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.